Home » Cancer Tests » Prostate Cancer – Risk of Recurrence

Prostate Cancer – Risk of Recurrence

The following test will assess Postate Cancer – Risk of Recurrence

Oncotype DX® Prostate Cancer Assay

Test available from: Oncotypeiq
The Oncotype DX Genomic Prostate Score (GPS) assay is the only genomic assay designed for men with clinically low-risk cancer to help make treatment decisions at the time of diagnosis. The assay analyzes prostate cancer gene activity to predict disease aggressiveness.
Article source: Oncotypeiq

Updated 2023

Cancer Tests

Please share this page to help others